'We strong­ly dis­sent': Women biotech ex­ecs pen let­ter to col­leagues and politi­cians in Roe v. Wade af­ter­math

In the days fol­low­ing the US Supreme Court’s roll­back of fed­er­al abor­tion rights, more than  100 women biotech ex­ec­u­tives came to­geth­er in an open let­ter to con­demn the rul­ing and tell their fel­low drug de­vel­op­ment lead­ers that they “will not stand by silent­ly.”

Ad­dressed to in­dus­try, friends, leg­is­la­tors and elect­ed of­fi­cials, the biotech ex­ec­u­tives said they were join­ing “the re­sound­ing mil­lions in cho­rus” by show­ing their “pro­found dis­may and dis­ap­point­ment” at the de­ci­sion hand­ed down by SCO­TUS last week, a re­ver­sal of Roe v. Wade that had been an­tic­i­pat­ed for weeks fol­low­ing a court leak.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER